Even if Paul knows something he cannot tell some one via email if it is material information so we got the response expected.
The rest of your post though is interesting as it could be that the recent sign up of quality distributors, the appearance of product OTC in pharmacies in Span and elsewhere and the inability of the company to market the product in UK and Germany despite having Amazon as the shipping agent could be positioning the company for a strategic move.
The GEO deal potentially opens doors to a buy out in Europe. Why not buy the company without a USA FDA clearance. If the product is being accepted there and the price is right it is what Andy should do even if the price "isnt obscene enough".
I wish I hadn't had to sell and now I have my ax refund may get back in but really waiting for concrete news, trouble is if the news is a buy out I miss the 2-5 times pop at the open.